Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists
Authors:
- 1 February 2025
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Psychiatry Research and Reviews
- Vol. 21 (1) , 2-14
Abstract
: Psychedelics are currently being examined once more as potential remedies for untreatable biological illnesses after decades of research problems. They are frequently regarded to be physically safe and do not frequently lead to dependency or addiction. The use of psychedelic substances in the treatment of mental illness and the adoption of the Substance Act of 1970 has classified psychedelic drugs as Schedule I. The major objective of this review is to highlight the prospective use of specific psychedelic medicines, such as psilocybin, LSD, MDMA, and ayahuasca, in the treatment of various psychiatric conditions, such as treatment-resistant depression, post-traumatic traumatic stress, end-of-life anxiety, and substance misuse disorders. As documented from both animal and human studies, in addition, there will be a study of the effectiveness and safety. The body of research suggests that psychedelics may one day offer revolutionary treatments for mental diseases, contrary to conventional therapy. However, given their distinctive histories and a high potential for abuse with widespread distribution, more care and effort must be given to protect their use as efficient medical treatments instead of drugs of abuse.Keywords
This publication has 65 references indexed in Scilit:
- Uncovering psychological mechanisms mediating the effects of drugs: some issues and comments using the example of psychedelic drugsPsychopharmacology, 2020
- Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine AdministrationBiological Psychiatry, 2018
- An introduction to psychedelic neuroscience2018
- Psilocybin with psychological support improves emotional face recognition in treatment-resistant depressionPsychopharmacology, 2017
- Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activationPsychopharmacology, 2017
- Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybinHuman Brain Mapping, 2015
- Serotonin and molecular neuroimaging in humans using PETAmino Acids, 2011
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage CancerArchives of General Psychiatry, 2011
- Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and ThalamusBiological Psychiatry, 2007
- Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J micePsychopharmacology, 2005